Koyfin Home > Directory > Health Care > Aimmune Therap > Return on Equity %

Aimmune Therap Return on Equity % Chart (AIMT)

Aimmune Therap annual/quarterly Return on Equity % from 2015 to 2020.
  • Aimmune Therap Return on Equity % for the quarter ending June 06, 2020 was -133.51 a -7.98% increase of 10.66 year over year
  • Aimmune Therap Return on Equity % for the last 12 months ending June 06, 2020 was -149.17 a 20.00% decrease of -29.83 year over year
  • Aimmune Therap Annual Return on Equity % for 2019 was -123.33 a 28.31% decrease of -34.92 from 2018
  • Aimmune Therap Annual Return on Equity % for 2018 was -88.41 a 35.94% decrease of -31.78 from 2017
  • Aimmune Therap Annual Return on Equity % for 2017 was -56.63 a 42.01% decrease of -23.79 from 2016
Other Margins & Efficiency Metrics:
  • Aimmune Therap Return on Capital % for the quarter ending September 09, 2018 was -49.51 a -8.25% increase of 4.08 year over year
View Chart On Koyfin

Quarterly AIMT Return on Equity % Data

06/2020-133.51
03/2020-203.93
12/2019-208.47
09/2019-144.17
06/2019-109.05
03/2019-78.19
12/2018-83.50
09/2018-77.31
06/2018-68.15
03/2018-78.12

Annual AIMT Return on Equity % Data

2019-123.33
2018-88.41
2017-56.63
2016-32.84
2015-34.62
2014-180.70